2016-08-242016-08-242015-03-31http://hdl.handle.net/10919/72751The present invention relates to the use of a therapeutically effective amount of abscisic acid (ABA) or its analogs to treat or prevent inflammation induced by exposure to lipopolysaccharide (LPS) or respiratory inflammation. The invention also relates to methods and composition for enhancing vaccine efficacy using ABA.application/pdfen-USMethod of preventing and treating inflammatory diseases and disorders with abscisic acidPatenthttp://pimg-fpiw.uspto.gov/fdd/24/936/089/0.pdf13700037424/204.1424/209.1424/211.1424/244.1424/278.1514/557A61K31/19A61K31/22A61K39/398993624